Ligand Pharmaceuticals Incorporated trailing returns
Ligand Pharmaceuticals Incorporated's 10-year return is +17.7% a year (CAGR) (+408.6% cumulative). How Ligand Pharmaceuticals Incorporated (LGND) has performed over the last day, week, month and year, over 5, 10, 20 and 30 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | -1.0% | +0.0% | -1.0% | — |
| 5 days | -2.1% | +0.0% | -2.1% | -5.2%Oct 14 |
| 1 month | +7.4% | +0.0% | +7.4% | -6.6%Oct 7 |
| YTD | +56.3% | +0.0% | +56.3% | -14.7%Sep 16 |
| 1 year | +63.5% | +0.0% | +63.5% | -14.7%Sep 2026 |
| 5 years | +29.5% | +0.0% | +29.5%+263.7% | -55.1%Jun 2022 |
| 10 years | +17.7% | +0.0% | +17.7%+408.6% | -76.9%Mar 2020 |
| 20 years | +10.3% | +0.0% | +10.3%+612.6% | -90.2%Nov 2008 |
| 30 years | +6.0% | +0.0% | +6.0%+474.2% | -95.0%Nov 2008 |
| Since inception (1992) | +5.6% | +0.0% | +5.6%+544.6% | -95.0%Nov 2008 |
Growth of LGND#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years+29.5%/year · +263.7%
- 10 years+17.7%/year · +408.6%
- 20 years+10.3%/year · +612.6%
- 30 years+6.0%/year · +474.2%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in LGND's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Ligand Pharmaceuticals Incorporated's 10-year return?
- Over the last 10 years, Ligand Pharmaceuticals Incorporated (LGND) returned about +17.7% a year annualized (+408.6% cumulative total return).
- What is Ligand Pharmaceuticals Incorporated's 20-year annualized return?
- Over the last 20 years, Ligand Pharmaceuticals Incorporated (LGND) compounded at about +10.3% a year (+612.6% cumulative).
- What is Ligand Pharmaceuticals Incorporated's 30-year annualized return?
- Over the last 30 years, Ligand Pharmaceuticals Incorporated (LGND) compounded at about +6.0% a year (+474.2% cumulative).
- What is Ligand Pharmaceuticals Incorporated's return since inception?
- Since 1992, Ligand Pharmaceuticals Incorporated (LGND) has compounded at about +5.6% a year — +544.6% in total.